What is the JUMP-Cell Painting Consortium?
Our data is now public! Learn more on the JUMP Hub!
Funded in part by the Bits to Bytes Capital Call of the Massachusetts Life Sciences Center (MLSC), the JUMP-Cell Painting Consortium created a new data-driven approach to drug discovery based on cellular imaging, image analysis, and high dimensional data analytics. We believe it will transform drug discovery by relieving a major bottleneck in the pharma pipeline: determining the mechanism of action of potential therapeutics prior to introduction into patients. We created an unprecedented public data set to validate and scale up this image-based drug discovery strategy. This valuable public resource is now available for other applications, including predicting compounds’ activity and toxicity, matching drugs to disease states, and more.
JUMP-CP created the necessary validation, technical know-how, and data to bring Cell Painting to bear on a key bottleneck in drug discovery, while nucleating and catalyzing the worldwide community that uses the technology. By coordinating assay procedures across the partners, future created data will be well-matched. Ultimately, we aim to make cell images as computable as genomes and transcriptomes.